PDF下载 ( 1480 KB)
Immune pathogenesis and immunomodulatory therapy of alcoholic liver disease
-
-
[1]Tenca A, Massironi S, Colli A, et al."Pseudotumoral"hepatic pattern in acute alcoholic hepatitis:a case report[J].World J Gas-troenterol, 2009, 15 (32) ∶4070-4074. [2]Lederer SL, Walters KA, Proll S, et al.Distinct cellular responses differentiating alcohol-and hepatitis C virus-induced liver cirrho-sis[J].Virol J, 2006, 3 (1) ∶98. [3]Slukvin II, Boor PJ, Jerrells TR.Initiation of alcoholic fatty liverand hepatic inflammation with a specific recall immune response in alcohol-consuming C57Bl/6mice[J].Clin Exp Immunol, 2001, 125 (1) ∶123-133. [4]Duryee MJ, Klassen LW, Jones BL, et al.Increased immunogenic-ity to P815cells modified with malondialdehyde and acetaldehyde[J].Int Immunopharmacol, 2008, 8 (8) ∶1112-1118. [5]Schaffert CS, Duryee MJ, Hunter CD, et al.Alcohol metabolites and lipopolysaccharide:roles in the development and/or progression of alcoholic liver disease[J].World J Gastroenterol, 2009, 15 (10) ∶1209-1218. [6]Day CP, Bassendine MF.Genetic predisposition to alcoholic liver disease[J].Gut, 1992, 33 (11) ∶1444-1447. [7] Tenca A, Massironi S, Colli A, et al."Pseudotumoral"hepatic pattern in acute alcoholic hepatitis:a case report[J].World J Gas-troenterol, 2009, 15 (32) ∶4070-4074. [8]Jurgens T, Whelan AM, MacDonald M, et al.Development and e-valuation of an instrument for the critical appraisal of randomized controlled trials of natural products[J].BMC Complement Altern Med, 2009, 23 (9) ∶11. [9]Bergheim I, McClain CJ, Arteel GE.Treatment of alcoholic liver disease[J].Dig Dis, 2005, 23 (3-4) ∶275-284. [10]Guha IN, Rosenberg WM.Future use of the Glasgowalcoholic hepa-titis score[J].Gut, 2006, 55 (1) ∶135-136. [11]Lee YM, Sutedja DS, Wai CT, et al.A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis[J].Hepatol Int, 2008, 2 (2) ∶196-201. [12]Tilg H, Jalan R, Kaser A, et al.Anti-tumor necrosis factor-al-pha monoclonal antibody therapy in severe alcoholic hepatitis[J].J Hepatol, 2003, 38 (4) ∶419-425. [13]Menon KV, Stadheim L, Kamath PS, et al.A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis[J].Am J Gastroenterol, 2004, 99 (2) ∶255-260. -
本文二维码
计量
- 文章访问数: 3270
- HTML全文浏览量: 8
- PDF下载量: 787
- 被引次数: 0
下载:
